Enhanced Symptom Management for Cancer
Trial Summary
What is the purpose of this trial?
This randomized controlled trial will assess the effects on quality of life of two approaches to symptom management among new patients referred to a palliative care oncology clinic.
Do I need to stop my current medications to join the trial?
The protocol does not specify if you need to stop your current medications.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the idea that Enhanced Symptom Management for Cancer is an effective treatment?
The available research shows that Enhanced Symptom Management for Cancer is effective because it focuses on improving the quality of life for patients by addressing pain, mental health, and other symptoms. For example, a study found that 69% of proposed quality indicators for symptom management were valid and feasible, which means they are practical and useful for evaluating and improving care. This includes managing pain, depression, and other symptoms like nausea and fatigue. Additionally, both patients and experts agree that high-quality care should be personalized and proactive, meaning it should be tailored to each patient's needs and involve regular check-ins to manage symptoms effectively. This approach is seen as critical for providing high-quality supportive cancer care.12345
What data supports the effectiveness of the treatment Offering Additional Resources to Promote Symptom Management, Palliative Care, Symptom Management for cancer?
Research shows that quality indicators for symptom management, such as pain and depression, are valid and feasible, suggesting that structured approaches to symptom management can improve care quality for cancer patients. Additionally, web and mobile-based interventions have been identified as promising tools for managing symptoms in advanced cancer, indicating that accessible resources can enhance symptom management.12345
What safety data exists for Enhanced Symptom Management for Cancer treatment?
The safety data for Enhanced Symptom Management for Cancer, which may also be known as Offering Additional Resources to Promote Symptom Management, Palliative Care, or Symptom Management, includes several studies. A pilot study on community palliative care patients showed a high prevalence of symptomatic events, indicating the need for further research. Another study highlighted the poorly understood harms of medications used in palliative care, which can impact compliance and contribute to symptoms. The Cancer Quality-ASSIST Project developed quality indicators for symptom management, emphasizing the need for adherence to recommended practices. Additionally, a study on a patient-reported information sharing system showed improved management of treatment-related adverse events. Lastly, guidelines for serious adverse event reporting in non-pharmacological palliative care trials were discussed, noting the challenges due to the high risk of hospitalization or death from disease progression rather than the trial interventions.26789
Is the Enhanced Symptom Management for Cancer treatment safe for humans?
Is the treatment in the trial 'Enhanced Symptom Management for Cancer' a promising treatment?
Yes, the treatment is promising because it focuses on improving the quality of life for cancer patients by managing symptoms effectively. It uses web and mobile-based tools to provide timely help, making it easier for patients to access care. This approach is seen as a valuable way to support people with advanced cancer.34101112
How is this treatment different from other cancer treatments?
Eligibility Criteria
This trial is for adults over 18 with cancer who are new patients at an outpatient palliative care clinic in Pennsylvania. It's not open to pregnant individuals or those who have previously used certain therapies focused on symptom management.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive symptom management and complete surveys every two weeks for 16 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Offering Additional Resources to Promote Symptom Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Abramson Cancer Center of the University of Pennsylvania
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Lead Sponsor